v3.26.1
STOCKHOLDERS' EQUITY AND MEZZANINE EQUITY (Tables)
3 Months Ended
Feb. 28, 2026
Class of Stock [Line Items]  
Schedule of warrants activity

As of February 28, 2026, the continuity of share purchase warrants is as follows:

Number of

Weighted Average

Remaining

  ​ ​ ​

warrants

  ​ ​ ​

Exercise price

  ​ ​ ​

life (Years)

Balance, November 30, 2025

$

Issued for PIPE financing

 

2,500,000

 

 

12.00

 

4.99

Issued on reverse recapitalization (Note 4)

 

20,922,133

 

 

11.50

 

4.99

Balance, February 28, 2026

 

23,422,133

 

11.55

 

4.99

As of February 28, 2026, the following share purchase warrants were outstanding:

Number of warrants outstanding

  ​ ​ ​

Exercise price

  ​ ​ ​

Expiry date

2,500,000

$

12.00

February 24, 2031

20,922,133

 

$

11.50

February 24, 2031

23,422,133

 

 

  ​

  ​

Common stock, subject to possible redemption  
Class of Stock [Line Items]  
Schedule of redeemable common stock

Redeemable common stock, November 30, 2024

  ​ ​ ​

$

Gross proceeds

300,000

Less: share issuance costs

 

(170)

Plus: adjust carrying value to redemption value

 

170

Redeemable common stock, November 30, 2025

 

300,000

Less: transfer to permanent equity

 

(300,000)

Redeemable common stock, February 28, 2026

$

Series A cumulative preferred stock, redeemable  
Class of Stock [Line Items]  
Schedule of redeemable common stock

Redeemable Series A Cumulative Convertible Preferred Stock, November 30, 2025

  ​ ​ ​

$

Gross proceeds

29,700,000

Allocation to warrant liability (Note 11)

 

(4,174,276)

Accretion

 

8,480

Redeemable Series A Cumulative Convertible Preferred Stock, February 28, 2026

$

25,534,204